SWTX
SWTX
Unknown sector · Unknown industry
Market read
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
SWTX Price Structure
Loading chart…
Loading timeframes…
News (last pull)
Headlines about SWTX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 111 days ago · Apr 29
- SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
- European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
- Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
- SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors
- SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Misses Revenue Estimates
SWTX research tape
2 dated scans, research, and events, newest first — the full record.